Sector | Healthcare | Compare with Sector peers |
Industry | Hospital & Healthcare Services | Compare with Industry peers |
Website | http://www.apollohospdelhi.com | |
Market Cap | 2,532.92 Cr. | |
Enterprise Value(EV) | 2,325.60 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 12.29 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 22.49 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 66.00 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 48.45 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 5.70 | Calculated using Price: 276.30 |
Dividend Yield | 1.09 | Period Ending 2023-03 |
No. of Shares Subscribed | 9.17 Cr. | 91,673,000 Shares |
FaceValue | 10 | |
About Indraprastha Medical Corporation Ltd. | ||
It offers a range of diagnostic, medical, and surgical facilities for the care of its patients. The company provides treatments in the areas of anaesthesiology, oncology, cardiology, neurology, orthopedics, nephrology, ophthalmology, nuclear medicine, pediatrics, physiotherapy and rehabilitation, psychiatry and psychology, radiology, urology and andrology, gastroenterology, gynecology and obstetrics, dermatology, dietetics and nutrition, and respiratory and sleep medicine. It also offers various surgical services, including dental, cardiothoracic, neuro, vascular, joint, plastic and cosmetic, and general surgeries. In addition, the company's diagnostic services include lab services, radio-diagnosis, nuclear medicine, endoscopy lab, bronchoscopy lab, and blood bank. Further, it offers ambulance and air ambulance services, as well as out patient consultation services. |
1 Day |
|
+1.32% |
1 Week |
|
+21.12% |
1 Month |
|
+58.72% |
3 Month |
|
+65.92% |
6 Month |
|
+77.04% |
1 Year |
|
+231.64% |
2 Year |
|
+305.95% |
5 Year |
|
+620.46% |
10 Year |
|
+595.40% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 17.02 | 11.68 | 11.55 | 9.11 | 11.93 | 17.05 | 0.86 | 19.6 | 24.44 | |
Return on Capital Employed (%) | 23.29 | 17.72 | 16.98 | 14.4 | 18.29 | 20.15 | 2.8 | 27.58 | 34.46 | |
Return on Assets (%) | 7.3 | 5.42 | 5.71 | 4.74 | 6.65 | 10.01 | 0.53 | 13.12 | 16.94 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 195 | 224 | 231 | 232 | 244 | 268 | 273 | 325 | 379 | 415 | |
Non Curr. Liab. | 53 | 46 | 42 | 62 | 54 | 42 | 43 | 43 | 46 | 46 | |
Curr. Liab. | 194 | 191 | 186 | 138 | 124 | 140 | 116 | 94 | 130 | 207 | |
Minority Int. | |||||||||||
Equity & Liab. | 442 | 461 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 668 | |
Non Curr. Assets | 293 | 308 | 301 | 299 | 287 | 308 | 291 | 304 | 332 | 365 | |
Curr. Assets | 149 | 152 | 158 | 133 | 136 | 141 | 141 | 157 | 223 | 302 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 442 | 461 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 668 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 714 | 755 | 766 | 753 | 788 | 831 | 613 | 888 | 1,099 | 1,204 | |
Other Income | 1 | 2 | 0 | 1 | 0 | 1 | 1 | 3 | 10 | 17 | |
Total Income | 715 | 758 | 766 | 753 | 789 | 831 | 614 | 891 | 1,109 | 1,221 | |
Total Expenditure | -630 | -676 | -687 | -680 | -707 | -744 | -573 | -774 | -948 | -1,026 | |
PBIDT | 86 | 82 | 79 | 74 | 81 | 87 | 41 | 117 | 161 | 195 | |
Interest | -8 | -7 | -8 | -9 | -7 | -6 | -3 | -3 | -4 | -3 | |
Depreciation | -28 | -35 | -31 | -31 | -30 | -33 | -33 | -35 | -39 | -40 | |
Taxation | -17 | -14 | -15 | -13 | -16 | -5 | -2 | -20 | -31 | -39 | |
Exceptional Items | |||||||||||
PAT | 32 | 24 | 26 | 21 | 28 | 44 | 2 | 59 | 86 | 113 | |
Adjusted EPS | 4 | 3 | 3 | 2 | 3 | 5 | 0 | 6 | 9 | 12 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 58 | 64 | 62 | 28 | 48 | 75 | 86 | 27 | 94 | 144 | |
Cash Fr. Inv. | -22 | -29 | -33 | -22 | -30 | -17 | -40 | -19 | -74 | -108 | |
Cash Fr. Finan. | -36 | -35 | -30 | -5 | -17 | -44 | -43 | -3 | -3 | -26 | |
Net Change | 0 | 0 | 0 | 0 | 1 | 14 | 4 | 5 | 17 | 11 | |
Cash & Cash Eqvt | 2 | 2 | 2 | 2 | 3 | 17 | 20 | 25 | 42 | 52 |
Wed, 10 Apr 2024
Disclosure under SEBI Takeover Regulations APOLLO HOSPITALS ENTERPRISE LIMITED has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
Tue, 09 Apr 2024
Credit Rating Indraprastha Medical Corporation Limited has informed the Exchange about Credit Rating |
Mon, 08 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Indraprastha Medical Corporation Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
Tue, 23 Apr 2024 |
Higher Delivery Quantity |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |
Close Crossing 52 Week High |
Closing Above Previous High |